Drug
Bupropion Hydrobromide
Bupropion Hydrobromide: highest development phase Post-Market, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| bupropion hydrobromide NCT02129751 | Post-Market | Major Depressive Disorder |
Latest
No recent events.
Follow Bupropion Hydrobromide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.